Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jeremy J. Pappacena"'
Autor:
Wenbin Xiao, Mariko Yabe, Michael Offin, Pallavi Khattar, Jeeyeon Baik, Ryan J. Daley, Jeremy J. Pappacena, Mikhail Roshal, Yanming Zhang, Martin S. Tallman, Sheng F. Cai
Publikováno v:
Blood Advances, Vol 2, Iss 13, Pp 1517-1521 (2018)
Externí odkaz:
https://doaj.org/article/bab066c3fee14dc8bb0ef941c011f21d
Autor:
Charlene C. Kabel, Mark B. Geyer, Sridevi Rajeeve, Jeremy J. Pappacena, Sarah E. Stump, Martin S. Tallman, Jessica A. Lavery, Ryan J. Daley, Jae H. Park
Publikováno v:
Leukemialymphoma. 62(1)
Pegaspargase is a modified version of asparaginase with prolonged asparagine depletion. It appears to be safe in adults40 years old, but has a unique spectrum of toxicities, the risks of which appear to increase with age. The primary objective of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0158962601d399b973941e615e8fd0c3
https://pubmed.ncbi.nlm.nih.gov/32985296
https://pubmed.ncbi.nlm.nih.gov/32985296
Publikováno v:
The Annals of pharmacotherapy. 53(9)
Objective: To review the literature for the treatment of classical and variant hairy cell leukemia (HCL, HCLv), evaluating efficacy, safety, and supportive care involved in the use of purine analogues (PAs), interferon, BRAF inhibitors, monoclonal an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f52c95ebfeee0751b1722bd2658847e
https://pubmed.ncbi.nlm.nih.gov/30841702
https://pubmed.ncbi.nlm.nih.gov/30841702
Publikováno v:
Leuk Res
Introduction: Incorporation of ABL-targeted oral tyrosine kinase inhibitors (TKIs) to conventional chemotherapy regimens has improved outcomes for adult patients (pts) with (w/) Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7afee8e09324e3fb1da1dbc039b90424
https://pubmed.ncbi.nlm.nih.gov/30831480
https://pubmed.ncbi.nlm.nih.gov/30831480
Autor:
Esperanza B. Papadopoulos, Brian C. Shaffer, Jeremy J. Pappacena, Ann A. Jakubowski, Patrick Hilden, Jennifer S. Orozco, Valkal Bhatt, Molly Maloy, Larry W Buie
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S276-S277
Introduction In patients with poor risk AML or MDS in first complete remission (CR1), alloSCT can be potentially curative. Comparison of the non-hematologic toxicities between total body irradiation (TBI)-based conditioning versus chemotherapy alone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e208814b857a9e65222e5e95304864e7
https://doi.org/10.1016/j.bbmt.2018.12.342
https://doi.org/10.1016/j.bbmt.2018.12.342
Autor:
Molly Maloy, Michael Scordo, Gunjan L. Shah, Patrick Hilden, Valkal Bhatt, Larry W Buie, Sergio Giralt, Jeremy J. Pappacena
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S330-S331
Background:Reduced-intensity conditioning (RIC) regimens such as Flu/Bu and Flu/Mel are commonly used for patients who are not medically fit for myeloablative conditioning (Shimoni Leukemia 2006). Recent studies have shown lower incidences of non-rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29a46a21cfd85ab89f1e06ed57e00080
https://doi.org/10.1016/j.bbmt.2017.12.271
https://doi.org/10.1016/j.bbmt.2017.12.271
Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia
Autor:
Jeremy J. Pappacena, Sridevi Rajeeve, Charlene C. Kabel, Mark B. Geyer, Martin S. Tallman, Jessica A. Lavery, Ryan J. Daley, Sarah E. Stump, Jae H. Park
Publikováno v:
Blood. 134:3816-3816
Introduction: Asparaginase (ASP) has demonstrated a survival benefit in pediatric patients (pts) with acute lymphoblastic leukemia (ALL) and is now part of standard-of-care frontline treatment. As a result, asparaginase preparations have been incorpo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88ce0def874fd2dba45b62b6584da68a
https://doi.org/10.1182/blood-2019-124727
https://doi.org/10.1182/blood-2019-124727